Trials / Not Yet Recruiting
Not Yet RecruitingNCT06446661
Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
Improving Oral Chemotherapy Adherence in Maintenance for Adolescents and Adults With Acute Lymphoblastic Leukemia Using Text Messages
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (estimated)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 15 Years – 39 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this section is to learn how text message reminders might help with regularly taking chemotherapy medications for Adolescents and Adults with Acute Lymphoblastic leukemia (ALL).
Detailed description
This study aims to compare adherence to oral mercaptopurine and methotrexate during the first 84-day cycle of maintenance therapy for adolescent and young adult patients with Acute Lymphoblastic Leukemia on pediatric-based regimens between those who receive the high intensity text message intervention and those who receive standard-of-care. It is believed that high-intensity text messages will increase patient adherence within cycle 1.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | High Intensity | Daily texts |
| OTHER | No Text Messagings | Standard Care |
| OTHER | Low Intensity Text Messaging | Weekly Texts |
Timeline
- Start date
- 2026-12-15
- Primary completion
- 2027-06-15
- Completion
- 2028-06-15
- First posted
- 2024-06-06
- Last updated
- 2026-03-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06446661. Inclusion in this directory is not an endorsement.